Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00195754
Status:
COMPLETED
Last Update Posted:
2007-07-31
First Post:
2005-09-13
Brief Title:
A Phase III Open-Label Multi-Center Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
The Safety of Divalproex Sodium Extended Release Tablets in Migraine Prophylaxis An Open-Label Extension Study in Adolescents
Status:
COMPLETED
Status Verified Date:
2007-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if long-term treatment up to 1 year with Depakote ER is safe in the reduction of occurrence of migraine headaches in adolescents
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None